Fortrea buys Worldwide Clinical Trials early phase unit for $45M
Tweet Send to a Friend
Fortrea (Nasdaq: FTRE) has completed its acquisition of the Early Phase Services division from Worldwide Clinical Trials in an all-cash ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




